KMDA · NASDAQ · Drug Manufacturers - Specialty & Generic

Kamada (KMDA)

Develops plasma-derived therapies and distributes biopharmaceutical products in Israel and the MENA region.

$8.75
vs last close−0.12 (−1.35%)